Carrie Liao
CIK 1899817 · Chief Accounting Officer · last filed 2025-03-26
Carrie Liao is a Chief Accounting Officer who has filed 8 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing shows the insider sold $15.8K of MNMD on Mar 26, 2025. Across all open-market trades the lifetime net is −$46.8K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
8
-$46.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (MNMD) Delisted | Chief Accounting Officer | 144,923 | $15.00 | $2.17M | -$46.8K | 8 | 2025-03-26 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-26 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −2,347 | -$15.8K | EDGAR |
| 2025-03-13 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2024-12-27 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −2,273 | -$16.9K | EDGAR |
| 2024-09-25 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −2,352 | -$14.1K | EDGAR |
| 2024-02-29 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-24 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +75,000 | $0 | EDGAR |
| 2023-03-17 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +75,000 | $0 | EDGAR |
| 2022-03-14 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +403,430 | $0 | EDGAR |